Ultragenyx Pharmaceutical Statistics

Total Valuation

LON:0LIF has a market cap or net worth of GBP 2.76 billion. The enterprise value is 3.00 billion.

Market Cap	2.76B
Enterprise Value	3.00B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	94.38M
Shares Outstanding	n/a
Shares Change (YoY)	+21.44%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	90.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.03
PB Ratio	23.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.06
EV / Sales	6.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.81

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 5.88.

Current Ratio	2.40
Quick Ratio	2.05
Debt / Equity	5.88
Debt / EBITDA	n/a
Debt / FCF	-2.25
Interest Coverage	-8.35

Financial Efficiency

Return on equity (ROE) is -377.06% and return on invested capital (ROIC) is -30.38%.

Return on Equity (ROE)	-377.06%
Return on Assets (ROA)	-24.51%
Return on Invested Capital (ROIC)	-30.38%
Return on Capital Employed (ROCE)	-50.34%
Revenue Per Employee	353,313
Profits Per Employee	-328,724
Employee Count	1,294
Asset Turnover	0.45
Inventory Turnover	18.87

Taxes

In the past 12 months, LON:0LIF has paid 1.90 million in taxes.

Income Tax	1.90M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.59%
50-Day Moving Average	36.19
200-Day Moving Average	44.60
Relative Strength Index (RSI)	62.12
Average Volume (20 Days)	104

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.68

Income Statement

In the last 12 months, LON:0LIF had revenue of GBP 457.19 million and -425.37 million in losses. Loss per share was -4.55.

Revenue	457.19M
Gross Profit	-141.11M
Operating Income	-397.49M
Pretax Income	-423.47M
Net Income	-425.37M
EBITDA	-369.87M
EBIT	-397.49M
Loss Per Share	-4.55

Full Income Statement

Balance Sheet

The company has 382.69 million in cash and 688.62 million in debt, giving a net cash position of -252.86 million.

Cash & Cash Equivalents	382.69M
Total Debt	688.62M
Net Cash	-252.86M
Net Cash Per Share	n/a
Equity (Book Value)	117.06M
Book Value Per Share	1.19
Working Capital	315.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -301.81 million and capital expenditures -4.34 million, giving a free cash flow of -306.14 million.

Operating Cash Flow	-301.81M
Capital Expenditures	-4.34M
Free Cash Flow	-306.14M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -30.87%, with operating and profit margins of -86.94% and -93.04%.

Gross Margin	-30.87%
Operating Margin	-86.94%
Pretax Margin	-92.63%
Profit Margin	-93.04%
EBITDA Margin	-80.90%
EBIT Margin	-86.94%
FCF Margin	n/a

Dividends & Yields

LON:0LIF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.44%
Shareholder Yield	n/a
Earnings Yield	-15.42%
FCF Yield	-11.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0LIF has an Altman Z-Score of -2.69 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.69
Piotroski F-Score	4